Bullboard - Stock Discussion Forum DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s): DHTRF

Healthcare

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

Add To Watchlist

TSX:DHT.UN - Post Discussion

DRI Healthcare Trust > Back in Business

View:

Post by retiredcf on Oct 04, 2024 8:53am

Back in Business

Following Thursday’s announcement of a US$57-million deal with Editas Medicine Inc. for a share of its annual license fees for the Cas9 gene-editing technology, CIBC’s Scott Fletcher raised his DRI Healthcare Trust (DHT.UN-T) target to $18.50 from $17.50 with an “outperformer” rating, , while Raymond James’ Michael Freeman increased his target to $23 from $20 with an “outperform” rating. The average is $18.68.

“We like deal’s elegant structure, its engagement with a highly innovative counterparty (potential for repeat business), and what it says about DRI’s dealmaking engine: it’s fully intact, and it’s revving high,” said Mr. Freeman.

125